You are here: Industry Insights > Beckman Coulter

News List

Beckman Coulter to Distribute BNP Cardiac Assay to Customers prnasia
July 27, 2021
Beckman Coulter, a global clinical diagnostics leader, announced that it has entered into definitive agreements with Quidel Corporation to obtain all rights related to the manufacture, distribution, and sale of a BNP assay for Beckman Coulter analyzers.
Beckman Coulter Offers $4/High-throughput Antigen Test to Support U.S. Government Initiative to Expand COVID-19 Testing prnewswire
March 19, 2021
Beckman Coulter announced their commitment to support the U.S. government's plan to invest more than $12 billion to expand COVID-19 testing with their high-throughput, high-quality lab antigen test, Access SARS-CoV-2 Ag,* ideal for mass screening testing.
Beckman Coulter Launches High-Throughput COVID-19 Antigen Test americanpharmaceuticalreview
December 28, 2020
Beckman Coulter announced the launch of a new test that addresses the three main barriers currently facing schools, businesses, hospitals and communities with the rollout of mass COVID-19 testing.
Beckman Coulter Receives Funding to Validate Monocyte Distribution Width in MIS-C Detection americanpharmaceuticalreview
October 22, 2020
Beckman Coulter has been awarded funding by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services ...
Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children prnewswire
October 16, 2020
Beckman Coulter, a global clinical diagnostics leader, today announced that it was awarded funding by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the Assistant Secretary for Preparedness and Response at ...
Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives Emergency Use Authorization americanpharmaceuticalreview
October 16, 2020
Beckman Coulter announced its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
Beckman Coulter Launches SARS-CoV-2 IgM Antibody Test and will begin shipping to U.S. Diagnostics Labs prnewswire
August 25, 2020
Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay.
SARS-CoV-2 IgG Antibody Test Receives FDA Emergency Use Authorization americanpharmaceuticalreview
July 08, 2020
Beckman Coulter announced its Access SARS-CoV-2 IgG assay has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA).
Beckman Coulter Announces Test Development for Coronavirus Antibodies americanpharmaceuticalreview
April 02, 2020
In response to the global COVID-19 pandemic, Beckman Coulter is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2.